Search

everythinglearnresearchcommunity

for

Search:↓

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Hormonal changes and social stress may link lupus and eating disorders in teens.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

A rare form of lupus can cause severe nerve damage and other symptoms, but treatment can help.

Different rheumatological diseases can cause specific skin problems.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Baricitinib improved hair loss and arthritis in a lupus patient.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Undiagnosed lupus can cause severe complications after epidural anesthesia, leading to muscle weakness and potentially death.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

A woman with lupus and severe nerve damage improved with specific treatments.

Retinoids may help treat lupus nephritis and reduce steroid use.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.